Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy针对磷脂酰肌醇蛋白农3的嵌合抗原受体T细胞的合理设计可使毒性与治疗效果脱钩CYTOTHERAPYIF3.22022-07-016OAAI
RATIONAL DESIGN OF CHIMERIC ANTIGEN RECEPTOR T CELLS AGAINST GLYPICAN 3 DECOUPLES TOXICITY FROM THERAPEUTIC EFFICACYJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-12-100PREAI
Synthesis and evaluation of pyrrolobenzodiazepine dimer antibody-drug conjugates with dual β-glucuronide and dipeptide triggersEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92019-10-0115PREAI
Selective activation of anti-CD73 mechanisms in control of primary tumors and metastasesONCOIMMUNOLOGYIF6.32017-05-0825OAAI
Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chainMABSIF7.32017-01-055OA
MEDI9447: enhancing anti-tumor immunity by targeting CD73 In the tumor microenvironmentCANCER RESEARCHIF16.62015-08-014PRE
Checkpoint inhibitor combinations in a human mixed leukocyte reactionCANCER RESEARCHIF16.62015-08-010PRE
Phenotypic selection for identification of functional antibodies and development of high throughput screening assays.CANCER RESEARCHIF16.62013-04-010PRE
Calculating the statistical significance of synergy in cancer drug combinations.CANCER RESEARCHIF16.62013-04-010PRE